DNASTAR® announced the release of Lasergene 16 Software

DNASTAR® announced the release of Lasergene 16 today, which includes a broad range of improvements in for analysis of DNA, RNA and protein sequence data, as well as new advancements for predicting and analyzing protein structures.

Written byDNASTAR
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

With Lasergene 16, DNASTAR has introduced an all-new protein design tool that enables researchers to identify residues that influence protein fold stability, by introducing specific variants to the wild-type structure or by scanning for hot-spot residues. Protein design simulations take seconds to complete – allowing researchers to perform high-throughput scanning of protein variations to support their downstream analysis and experimentation. Findings from the protein design workflow can also be used to guide PCR based site-directed mutagenesis using the Lasergene Molecular Biology software. By integrating structure and sequence-based analysis, Lasergene users can expect to save days of time on mutagenesis experiments.

NovaFold, part of Lasergene Protein and powered by the award-winning I-TASSER algorithm for protein structure prediction, now further enhances the quality of its world-leading structure predictions. A new structure-refinement protocol improves bond geometries, removes atomic clashes, and creates energetically minimized structure models. These improvements amount to more accurate structure models ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Graphic of amino acid chains folded into proteins

Expi293™ PRO Expression System: Higher Yields Across a Wider Variety of Proteins

Thermo Fisher Logo